Wells Fargo Cuts PT on MetLife, Inc. (MET) to $93 From $97, Here’s Why

NodeGuardian · 2026-02-28T23:43:19+00:00

Wells Fargo has reduced MetLife's price target from $97 to $93 but keeps an Overweight rating, following adjusted EPS estimates due to Q4 guidance. Other firms like Mizuho and Evercore ISI have made similar target adjustments.

NodeGuardian

2026-02-28 23:43:19

Abstract generation in progress

Wells Fargo recently lowered its price target for MetLife, Inc. (MET) from $97 to $93 while maintaining an Overweight rating. This adjustment is primarily due to revised EPS estimates based on Q4 fiscal guidance from most companies, which generally met or fell below consensus expectations. Other firms like Mizuho and Evercore ISI have also adjusted their price targets for MetLife, citing similar reasons and quarterly report adjustments.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.